Company misled investors on possible Alzheimer’s drug, SEC charges Science Magazine Par : Charles Piller 30 septembre 2024 à 06:57 Agency fines Cassava $40 million, and two of its employees lesser amounts, over research on simufilam
Did a top NIH official manipulate Alzheimer's and Parkinson’s studies for decades? Science Magazine Par : Charles Piller 26 septembre 2024 à 11:00 Agency announces research misconduct finding for neuroscientist Eliezer Masliah as scores of his papers fall under suspicion